EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Iron supplementation during human immunodeficiency virus infection: a double-edged sword?



Iron supplementation during human immunodeficiency virus infection: a double-edged sword?



Medical Hypotheses 57(4): 476-479



Although iron supplementation is considered beneficial for groups at risk for anemia, concern has been raised that it could be harmful during human immunodeficiency virus (HIV) infection. Studies suggest: (1) faster HIV disease progression in thalassemia major patients receiving inadequate doses of iron-chelating drug; (2) higher mortality among patients receiving iron supplementation with dapsone compared with aerosolized pentamidine for prophylaxis against Pneumocytis carinii pneumonia; (3) higher iron stores and mortality among patients with haptoglobin Hp 2-2 phenotype; and (4) shorter survival among patients with high bone marrow iron deposition. These studies largely involved men in developed countries. Among HIV-infected pregnant women in Africa with a high prevalence of iron deficiency, no relationship was found between indicators of iron status and HIV disease severity. The available data do not contraindicate the current practice of iron supplementation in developing countries where there is a high prevalence of both HIV infection and iron deficiency.

(PDF emailed within 0-6 h: $19.90)

Accession: 010885402

Download citation: RISBibTeXText

PMID: 11601873

DOI: 10.1054/mehy.2001.1368



Related references

Micronutrient supplementation and infection: a double-edged sword?. Journal of Pediatric Gastroenterology and Nutrition 34(4): 346-352, 2002

Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?. Nephrology, Dialysis, Transplantation 20 Suppl 7: Vii16-Vii23, 2005

Autoimmunity and HIV/simian immunodeficiency virus infection: A two edged sword. Hepatology Research 37 Suppl 3: S389-S395, 2007

NK cells: a double-edged sword in chronic hepatitis B virus infection. Frontiers in Immunology 4: 57-57, 2013

Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword. Journal of Clinical and Translational Hepatology 1(2): 103-108, 2013

Thiamine supplementation to cancer patients: a double edged sword. Anticancer Research 18(1b): 595-602, 1998

Iron: a double-edged sword. Transfusion 57(10): 2293-2297, 2017

Iron and immunity: A double-edged sword. European Journal of Clinical Investigation 32(Suppl 1): 70-78, March, 2002

Dietary iron in Parkinson's disease: a double edged sword. Lancet Neurology 3(12): 699-699, 2004

Iron and copper in male reproduction: a double-edged sword. Journal of Assisted Reproduction and Genetics 32(1): 3-16, 2015

Iron and Its Role in Cancer Defense: A Double-Edged Sword. Metal Ions in Life Sciences 18, 2018

Iron metabolism: a double-edged sword in the resistance of glioblastoma to therapies. Trends in Endocrinology and Metabolism: Tem 26(6): 322-331, 2016

DC-virus interplay: a double edged sword. Seminars in Immunology 16(3): 147-161, 2004

Elevated catalase expression in a fungal pathogen is a double-edged sword of iron. Plos Pathogens 13(5): E1006405-E1006405, 2017

Intravenous iron therapy in patients with heart failure. A double-edged sword. International Journal of Cardiology 168(5): 4863-4863, 2014